Combined effects of niclosamide and temozolomide against human glioblastoma tumorspheres

PURPOSE: Glioblastoma (GBM) is the most aggressive type of brain tumor and has poor survival outcomes, even after a combination of surgery, radiotherapy, and chemotherapy. Temozolomide is the only agent that has been shown to be effective against GBM, suggesting that combination of temozolomide with...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Cancer Res Clin Oncol
Päätekijät: Oh, Hyeong-Cheol, Shim, Jin-Kyoung, Park, Junseong, Lee, Ji-Hyun, Choi, Ran Joo, Kim, Nam Hee, Kim, Hyun Sil, Moon, Ju Hyung, Kim, Eui Hyun, Chang, Jong Hee, Yook, Jong In, Kang, Seok-Gu
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer Berlin Heidelberg 2020
Aiheet:
Original Article – Cancer Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7519913/
https://ncbi.nlm.nih.gov/pubmed/32712753
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00432-020-03330-7
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia